
Shortages of the medication which allows people with pancreatic cancer to digest food must be urgently addressed, the charity Pancreatic Cancer UK has said.
Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb nutrients.